Tag Archives: big pharma

SYMJEPI Defect Recall

Imagine having an allergic reaction and the medication to save your life cannot be dispensed. SYMJEPI is an emergency treatment for patients who have an allergic reaction to something or anaphylaxis to stinging insects, allergen immunotherapy, foods, drugs, diagnostic testing substances and more.  This injection is an emergency Epinephrine medication that is injected into patient…
Read more

Overcoming the Challenges of Small Batch Production

Focusing on a targeted group of patients and trials has led to more small batch productions throughout the industry. These products are often expensive and very limited within the pharmaceutical industries. When having a limited amount of product for manufacturing, issues and rejects must be near zero. Although, product loss is unavoidable—most product loss is…
Read more

Breaking Through Glass Ceiling of Pharmaceutical Packaging

The creation of intravenous solutions, has led the standard practice of using glass for packaging.  Having a glass package for parenteral drugs has been tested and studied in the biopharma industry, giving reasoning to why having glass containers are currently the best solution for parenteral packaging.  Although, it may seem like the “best” solution as…
Read more

Serialization Challenges of Track & Trace in the Biopharma Industry

10% of drugs sold around the world are fake.  Counterfeit medicines are the cause of on average 1 million deaths yearly.  Increasing of online purchases and disrupted supply chains have intensified and made the risk of counterfeit medicines due to COVID-19. Drugs are “tracked” once after the product has left the manufacturer and landed where…
Read more